| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/28/2007 | CN1921820A Composition for treating a dermatological inflammatory response and method of preparation thereof |
| 02/28/2007 | CN1921758A Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseases |
| 02/28/2007 | CN1920131A Pharmaceutical polyacrylonitrile fiber for preventing and curing mammary gland hyperplasia, preparation and application thereof |
| 02/28/2007 | CN1920036A Macaque progesterone acceptor gene fragment and application thereof |
| 02/28/2007 | CN1919875A Cryptoporus volvatus polysaccharide, preparation and application thereof |
| 02/28/2007 | CN1919874A Antibody molecule ATF-Fc fusion albumen of antiurokinase type fibrinolysin activator receptor and use thereof |
| 02/28/2007 | CN1919861A 20(s)-protopanaxadiol glycosylated derivative and preparation method and application thereof |
| 02/28/2007 | CN1919857A Preparation method and application of water-soluble mangiferin monosodium salt |
| 02/28/2007 | CN1919856A Caulis trachelospermi total lignans extractive, extraction method and medicine use of the extractive and active constituent thereof |
| 02/28/2007 | CN1919853A Phosphor isoquinolinone, derivative, synthesis method and use thereof |
| 02/28/2007 | CN1919848A bilobalide K and complex thereof, preparation method and use for the same |
| 02/28/2007 | CN1919847A Novel hydrochloride compound and use thereof |
| 02/28/2007 | CN1919846A Novel oriented synthesis method of voriconazole, medicinal salt and intermediate thereof |
| 02/28/2007 | CN1919339A Cucurbitacin nano preparation comprising protein, preparation method and use thereof |
| 02/28/2007 | CN1919336A Method for preparing high activity long-acting PEG-interferon position isomer hybrid medicine |
| 02/28/2007 | CN1919309A Medicine for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919302A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919299A Medicine for toxin removing, clots absorbing and body strengthening |
| 02/28/2007 | CN1919298A Medicine for treating sexual disorder and enhancing sexuality |
| 02/28/2007 | CN1919268A Mouth-wash medicine for treating stomatocace and preparation method thereof |
| 02/28/2007 | CN1919266A Medicine composition for treating cardiovascular and cerebrovascular diseases, preparation method and use thereof |
| 02/28/2007 | CN1919255A Aim Naoluotong drop pill and its preparation method |
| 02/28/2007 | CN1919254A Pharmaceutical compositions and its application |
| 02/28/2007 | CN1919253A Cardiac and cerebral vascular disease treating medicinal composition |
| 02/28/2007 | CN1919252A Medicine for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919251A Traditional Chinese medicine composition for treating cardiac vascular disease |
| 02/28/2007 | CN1919250A Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919249A Chinese traditional medicine for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919248A Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919247A Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919246A Traditional Chinese medicine for treating cardiovascular diseases |
| 02/28/2007 | CN1919245A Traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
| 02/28/2007 | CN1919244A Chinese traditional medicine for treating cardiovascular disease |
| 02/28/2007 | CN1919243A Traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
| 02/28/2007 | CN1919241A Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919239A Traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
| 02/28/2007 | CN1919238A Medicine for treating cardiovascular and cerebrovascular disease |
| 02/28/2007 | CN1919237A Medicine for treating cardiovascular and cerebrovascular diseases |
| 02/28/2007 | CN1919236A Medicine for treating cardiovascular and cerebrovascular diseases |
| 02/28/2007 | CN1919235A Cardiac and cerebral vascular disease treating pharmaceutical composition |
| 02/28/2007 | CN1919234A Application of pharmaceutical composition in the process of preparing medicine for preventing and treating plateau cardiac muscle hypoxidosis |
| 02/28/2007 | CN1919233A Nourishing and health care capsule with intelligence development and memory improvement function and method for making same |
| 02/28/2007 | CN1919226A Nose-plug medicine for treating chronic rhinitis and its preparing process |
| 02/28/2007 | CN1919223A Medicinal composition of notoginsen triterpenes and notoginsenoside |
| 02/28/2007 | CN1919222A Process for preparing notoginsen triterpenes |
| 02/28/2007 | CN1919219A Refining method of ginko total chromocor and method for preparing ginko damo injection |
| 02/28/2007 | CN1919209A Pharmaceutical composition for healing skin wound |
| 02/28/2007 | CN1919208A Medicine for treating epithelium tumor |
| 02/28/2007 | CN1919207A Gariic and medlar capsule |
| 02/28/2007 | CN1919206A Vitexin injection and oral administration preparation thereof |
| 02/28/2007 | CN1919205A Pharmaceutical composition comprising oxymatrine and baicalin |
| 02/28/2007 | CN1919204A Method for enhancing nutrient absorption with astragalosides |
| 02/28/2007 | CN1919203A Method for enhancing nutrient absorption with astragalosides |
| 02/28/2007 | CN1919202A Pharmaceutical composition of pharmacy acceptable salt of carthamus tinctorius yellow colour and ferulaic acid |
| 02/28/2007 | CN1919201A Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 02/28/2007 | CN1919200A Method for inhibiting bone resorption |
| 02/28/2007 | CN1919199A Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 02/28/2007 | CN1919198A Piroxicam medicinal preparation and preparing method thereof |
| 02/28/2007 | CN1919197A Slow release drop pills comprising toraesmide active ingredient and method for preparing same |
| 02/28/2007 | CN1919196A Slow release tablet comprising toraesmide active ingredient |
| 02/28/2007 | CN1919195A Vinpocetine drop pills and its preparation method |
| 02/28/2007 | CN1919194A Liquid composition of sirolimus |
| 02/28/2007 | CN1919193A Application of biphenyl cyclo-octadiene lignans for reducing toxic and side effect of antitumor agent |
| 02/28/2007 | CN1919192A Curcumenol self-emulsifying capsule and preparation method thereof |
| 02/28/2007 | CN1919191A Application of ring icariine in the preparation of medicine for preventing and treating organ transplantation rejection |
| 02/28/2007 | CN1919190A Composite intravenous injection emulsion of paclitaxel and traditional medicine volatile oil and its preparation process |
| 02/28/2007 | CN1919189A Ibuprofen granule and preparing method thereof |
| 02/28/2007 | CN1919188A Ibuprofen medicinal preparation and preparing method thereof |
| 02/28/2007 | CN1919187A Application of paeonol for preventing and treating fatty liver disease |
| 02/28/2007 | CN1919186A Tacrolimus oral administration preparation |
| 02/28/2007 | CN1919185A Compound ammonium glycyrrhizinato S dispersed tablet and its preparing process |
| 02/28/2007 | CN1919184A Mycophenolate mofetile dispersed tablet and preparation method thereof |
| 02/28/2007 | CN1919183A Pilocarpine nitrate dispersible tablet and preparation method thereof |
| 02/28/2007 | CN1919182A Mucosal delivery tablet |
| 02/28/2007 | CN1919180A Anticancer slow release agent of nimustine and its progression agent |
| 02/28/2007 | CN1919179A Anticancer slow release preparation of nimustine and its progression agent |
| 02/28/2007 | CN1919178A Nimustine slow release injection for treating noumenal tumour |
| 02/28/2007 | CN1919177A Nimustine slow release agent for treating noumenal tumour |
| 02/28/2007 | CN1919176A Anticancer slow release agent of nimustine and its progression agent |
| 02/28/2007 | CN1919175A Medicinal composition of nimustine and its progression agent |
| 02/28/2007 | CN1919174A Anticancer slow release agent of nimustine and its progression agent |
| 02/28/2007 | CN1919173A Nimustine slow release injection for treating extracranial noumenal tumour |
| 02/28/2007 | CN1919172A Anticancer slow release agent of nimustine and its progression agent |
| 02/28/2007 | CN1919171A Medicinal composition of nimustine and its progression agent |
| 02/28/2007 | CN1919170A Colloid pectin bismuth dry suspensoid and its preparing process |
| 02/28/2007 | CN1919169A Penciclovir emulsifiable paste and its preparation |
| 02/28/2007 | CN1302107C Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth |
| 02/28/2007 | CN1302103C CD 19XCD3 specific polypeptides and uses thereof |
| 02/28/2007 | CN1302007C Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 02/28/2007 | CN1301998C New process for the preparation of vinyl pyrrolidinone cephalosporine derivatives |
| 02/28/2007 | CN1301997C Benzosulfones with calcium antagonist activity |
| 02/28/2007 | CN1301996C Novel anticancer conjugates of camptothecin and unsaturated fatty acids |
| 02/28/2007 | CN1301994C Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 02/28/2007 | CN1301993C Dimeric compounds and their use as anti-viral agents |
| 02/28/2007 | CN1301991C Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 02/28/2007 | CN1301987C 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 02/28/2007 | CN1301982C Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
| 02/28/2007 | CN1301981C Medicinal composition containing 1,3-thiazine derivative |
| 02/28/2007 | CN1301980C Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 02/28/2007 | CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |